Related Experiment Video
Updated: Jun 13, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
Jolita Mereckiene1, Suzanne Cotter, Pierluigi Lopalco
1Health Protection Surveillance Centre, Dublin, Ireland; Vaccine European New Integrated Collaboration Effort (VENICE) Project, Italy. jolita.mereckiene@hse.ie
Abstract:
In January 2009 25 European Union (EU) Member States (MSs), Norway and Iceland, participated in a survey seeking information on national hepatitis B vaccination programmes. Details of vaccination policy, schedule, population groups targeted for vaccination, programme funding, vaccine coverage and methods of monitoring of vaccine coverage were obtained. Twenty (74%) countries reported that they have a universal hepatitis B vaccination programme, in addition to immunisation of at risk groups; seven (26%) countries recommend HBV for high risk groups only (with some inter-country variation on groups considered at high risk). Among countries without universal hepatitis B vaccination programmes, the major factor for non-introduction is low disease endemicity.
Related Concept Videos
Hepatitis
Vaccinations
Viral Hepatitis I: Introduction
Smallpox
Microorganisms in Medicine and Therapeutics
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
